Streetbeat News

Corporate Responsibility

TNDM

Tandem Diabetes Care, Inc. has launched Tandem Source, a new diabetes management platform that consolidates features from previous offerings into one central platform. It provides comprehensive data reporting for insulin pump users and healthcare providers, with easy-to-use reports, automatic data transfers, and a web-based pump uploader. The platform is now available in the U.S., with international availability expected in 2024. Early feedback has been positive, and the company plans to expand access to other countries next year.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:16 pm

GSD

Global System Dynamics, Inc. (GSD) announced an additional one-month extension to complete its initial business combination, now set for January 9, 2024. The extension is made possible by a $29,816.63 contribution from its sponsor, DarkPulse, Inc., to GSD's trust account. This contribution increases the pro rata funds available to stockholders in the event of a business combination or other redemption event by $0.0625 per share. The funds are provided as a non-interest bearing loan to be repaid upon a business combination or liquidation.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:03 pm

VEON

Kyivstar, a subsidiary of VEON Ltd., experienced a significant cyber-attack on December 12, 2023, disrupting communication services. Technical teams have partially restored fixed-line services and aim to begin full recovery from December 13. VEON supports Kyivstar's efforts and is working with Ukrainian authorities. The financial impact is currently unquantifiable and depends on the duration of service disruption. VEON will keep stakeholders informed on the progress.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:59 pm

MRNA

Moderna's stock price has declined following the company's announcement of changes to its operating model aimed at aligning with its short- and long-term business objectives.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:37 pm

AAPL

PYPL

Apple Inc (AAPL) has offered to let competitors use its tap-and-go payment technology to address EU antitrust charges and avoid fines. The EU had charged Apple with restricting access to its NFC technology, affecting competitors' mobile wallet services. PayPal Holdings, Inc (PYPL) was key in bringing a formal complaint to the EU. The European Commission will seek feedback on Apple's proposal next month. Meanwhile, Apple is also involved in a legal battle over a potential €13 billion tax bill to Ireland.

Portfolio Pulse from Anusuya Lahiri

December 12, 2023 | 7:36 pm

MRNA

Moderna's stock price fell 5.5% to $77.51 following the announcement of changes to its operating model aimed at aligning with its business goals. Additionally, the company's Chief Commercial Officer has stepped down, and Morgan Stanley has reduced its target price for Moderna to $92.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:34 pm

NFLX

Netflix has publicly released viewership data for all its shows and films for the first time, providing transparency into the popularity of its content. This move could help Netflix attract new talent and partnerships by showcasing the success of its platform.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:31 pm

GM

General Motors (GM) and Komatsu Ltd. have announced a partnership to co-develop a hydrogen fuel cell power module. This module is intended for use in Komatsu's 930E electric drive mining truck. The collaboration aims to integrate GM's advanced technology into Komatsu's vehicles to enhance their efficiency and environmental performance.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:08 pm

ABBV

EOLS

RVNC

SUPN

Public Citizen, a consumer advocacy group, has petitioned the FDA to enforce stronger warnings on botulinum toxin injections like AbbVie's Botox, Revance Therapeutics' Daxxify, Evolus' Jeuveau, and Supernus Pharmaceuticals' Myobloc. The group cites over 5,400 adverse event reports and calls for clear labeling of the risk of systemic iatrogenic botulism, which can cause muscle paralysis. The FDA is set to review the petition.

Portfolio Pulse from Vandana Singh

December 12, 2023 | 7:04 pm

BNTX

MRK

MRNA

PFE

Moderna Inc (NASDAQ:MRNA) is restructuring its operating model to prioritize sales of its COVID-19 vaccine, Spikevax, and the launch of its RSV vaccine in 2024. CEO Stephane Bancel will oversee sales and marketing, while President Stephen Hoge will handle pipeline commercial strategy. Arpa Garay is expected to leave the company. Moderna and Merck & Co Inc (NYSE:MRK) initiated a Phase 3 trial for a cancer therapy. MRNA shares fell 5.54% to $77.47. A patent victory for Pfizer Inc (NYSE:PFE)/BioNTech SE (NASDAQ:BNTX) was also noted.

Portfolio Pulse from Vandana Singh

December 12, 2023 | 6:38 pm